Burger's medicinal chemistry and drug discovery.
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Wiley,
1995-
|
| Edition: | Fifth edition / |
| Subjects: |
Table of Contents:
- v. 1. Principles and practice
- Drug discovery process
- Conceptual background and development of medicinal chemistry
- Management of drug discovery
- Intellectual property in drug discovery and biotechnology
- Information science in drug discovery
- Product development issues
- Drug absorption, distribution and elimination
- Drug metabolism
- Drug allergy
- Application of structural concepts to the predicition of the carcinogenicity of therapeutic agents
- From discovery to market: the development of pharmaceuticals
- Structural medicinal chemistry
- Three dimensional structure-aided drug design
- Drug receptors
- Drug-target binding forces
- Drug discovery technologies
- Chemical information computing systems in drug discovery
- Quantitative analysis of structure-activity relationships
- Molecular modeling in drug design
- Application of recombinant DNA technology in medicinal chemistry and drug discovery
- Mass ligand screening as a tool for drug and development discovery
- Approaches to the rational design of enzyme inhibitors
- Analog design
- Peptidomimetics for drug design
- Oligonucleotide therapeutics
- Carbohydrate-based therapeutics
- Metabolic considerations in prodrug design
- Natural products as leads for new pharmaceuticals
- v. 2 - Therapeutic agents
- Part I - Gastrointestinal drugs
- Cholinergics
- Anticholinergic drugs
- Gastric proton pump inhibitors
- Part IIA - Cardiovascular drugs, pt 1
- Cardiac drugs
- Part IIB - Cardiovascular drugs, pt 1
- Antihypertensive agents
- Phenoxyacetic and uricosuric diuretics
- Diuretic and urcosuric agents
- Part III - Chemotherapeutic agents, pt 1
- Aminoglycoside, macrolide, glycopeptide, and miscellaneous antibacterial antibiotics
- Sulfonamides and sulfones
- Antimycobacterial agents
- Antifungal agents
- v. 3. part. I. CNS drugs
- General anesthetics
- Antiparkinsonism drugs
- Sedatives and hypnotics
- Anticonvulsants
- Agents used in neurodegenerative disorders
- Analgesics.
- Part II. Male sex hormones and analogs
- Antiallergic agents
- Retinoids
- Insulin analogs
- v.4. Therapeutic agents
- Pt. 1. Radiological agents
- Radiosensitizers and radioprotective agents
- Pt. 2. Cardiovascular drugs
- Myocardial infarction agents
- Endogenous vasoactive peptides
- Hematopoietic agents
- Anticoagulants, anthrombotics, and hemostatics
- Pt. 3. Chemotherapeutic agents
- Synthetic antibacterial agents
- Lactam antibiotics
- Update on antiamebic agent development: clinical results and experience
- Anthelminitic agents
- Update on anthelmintic agent development: clinical results and experience
- Antiamebic agents
- Chemotherapy of African trypansomiasis
- Antiviral agents, DNA
- Pt. 4. Endocrine Drugs
- Female sex hormones and analogs
- Agents affecting the immune response
- v.5 - Therapeutic agents
- Pt. 1. Chemotherapeutic agents, pt. 3
- Antimalarial agents
- Pt. 2. CNS drugs, pt. 2
- Cognition enhancers, agents, and pharmacodynamic models for alzheimer's disease
- Antidepressant agents
- Antianxiety agents
- Antipsychotic agents
- Pt. 3. Endocrine drugs, pt. 2
- Antihistamines, topical ocular
- Antiinflammatory steroids
- Agents affecting the action of prostaglandins
- Agents affecting the action of leukotrienes and thromboxanes
- Histamine H1 receptor antagonists
- Antiviral agents, RNA viruses other than HIV
- Pt. 4. Radiological agents, pt. 2
- Radiopaques